-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-5-protocol-update-2023.pdf
January 01, 2023 - • Interventions designed to simultaneously
target PTSD and comorbid conditions other
than SUD if … SUD substance class and specific substance target
18.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rfviia.pptx
May 01, 2010 - Refining Key Questions: Interactive Case Study Quiz
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs. Usual Care in the Hospital Setting
Prepared for:
Agency for Healthcare Research and Quality (AHRQ)
www.ahrq.gov
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs.…
-
effectivehealthcare.ahrq.gov/sites/default/files/rfviia.pptx
May 01, 2010 - Refining Key Questions: Interactive Case Study Quiz
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs. Usual Care in the Hospital Setting
Prepared for:
Agency for Healthcare Research and Quality (AHRQ)
www.ahrq.gov
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs.…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-liver-metastases-therapies_research-protocol.pdf
September 27, 2012 - radiation
therapy that delivers a high dose of radiation with high targeting accuracy to an
extracranial target … Grading the Evidence for Each Key Question
Selected studies will be assessed for relevance against target
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/binge-eating-disposition-160504.pdf
December 09, 2015 - The target populations are
clearly defined. … Target audience and population were well-defined.
Key Q were appropriate and adequately stated. … The target population
and audience are clearly and explicitly described, as are the key
questions. … No response required.
27 TEP Reviewer
#5
General
Comments
The target population, audience, and … (the
other target would be the traditional clinical symptom) that could be
grounded in more basic
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-de-novo-processes_methods.pdf
September 01, 2009 - M
Methods Guide for
Comparative Effectiveness Reviews
Using Existing Systematic Reviews To Replace
De Novo Processes in Conducting Comparative
Effectiveness Reviews
Comparative Effectiveness Reviews are systematic reviews of existing research on the effectiveness,
comparative effectiv…
-
effectivehealthcare.ahrq.gov/sites/default/files/systematicreviewsreplacedenovo.pdf
September 01, 2009 - M
Methods Guide for
Comparative Effectiveness Reviews
Using Existing Systematic Reviews To Replace
De Novo Processes in Conducting Comparative
Effectiveness Reviews
Comparative Effectiveness Reviews are systematic reviews of existing research on the effectiveness,
comparative effectiv…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dementia-agitation-aggression_research-protocol.pdf
November 13, 2014 - and the framework(s)
underpinning an intervention determine its rationale.14 Interventions may also target
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-agitation-aggression_disposition-comments.pdf
March 21, 2016 - Section) does not enable to identify the target of aggressive
behaviors. … that it is
specifically the class of antipsychotics not all psychotropic
medications that is the target … there is bias in this
approach, still this is the common naturalistic mechanism for
tracking these target … My overall rating of Good is
with the assumption that the target audience is specific and expert in … The limits on defining the target population are
inherent to the research in this area, not attributable
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/transitions-care-pediatric-to-adult-services-disposition-comments.pdf
May 31, 2022 - Peer (TEP)
Reviewer #7
General The authors do not explicitly identify a target
audience for their … intended audience
and have added this to the main points and background of
the report stating: The target … Peer (TEP)
Reviewer #8
General As for the target population, presumably the
focus is on the pediatric … We highlight our target audience in the main points and
background stating: The target audience for … The target populations are clearly defined, and I
think the authors did a nice job of describing the
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hospital-length-of-stay-disposition-comments_0.pdf
September 20, 2021 - represents an opportunity
to decrease length of in hospital stay with interventions specifically
target
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_disposition-comments.pdf
September 15, 2014 - The
target population and audience for the report is
explicitly stated. … studies making it difficult for
a physician to make a clinical judgment regarding
vitamin D intake and target … The target
population is well defined. The key questions to be
answered are very clear. … The goal in individual should not be to be greater than
50 or 70 nmol/L but rather these should be target
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/coronary-artery-stenting_executive.pdf
February 01, 2013 - One nonrandomized study reported no statistical difference
between groups in repeat target lesion revascularization … For the composite
outcome of MACE (defined as death, MI, and target lesion
revascularization) in this … The 1-year composite outcome of death, MI, and ischemia-driven
target vessel revascularization was not … between groups for the clinical
outcomes of mortality or MI, but found a significant
difference in target
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
April 17, 2012 - The Healthcare Horizon Scanning
System provides AHRQ a systematic process to identify and monitor target … technologies and
innovations in health care and to create an inventory of target technologies that … pharmaceuticals or biotechnologies or in phase II or a trial with some preliminary efficacy data on
the target … adverse side effects could deter patients from opting for EndoBarrier treatment, others noted that
the target
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-informed-care-protocol.pdf
April 19, 2023 - Trauma Informed Care
Evidence-based Practice Center Systematic Review Protocol
Project Title: Trauma Informed Care
I. Background and Objectives for the Systematic Review
Exposure to adverse and potentially traumatic experiences is common and may influence the
health of millions of individuals. Trauma exp…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-204-obesity-disposition-comments.pdf
December 01, 2017 - I do not recall that the
authors explicitly defined the target population or audience. … strength and
weakness, or for one particular survey instrument in terms of
reliability, validity and target … For survey instrument’s, it
will be nice to have a summary about their reliability, validity,
target
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-liver-metastases-therapies_disposition-comments.pdf
December 11, 2012 - The target population and key questions are properly defines. … Commentator &
Affiliation Section Comment Response
Peer Reviewer #6
General
Comment
The target … Peer Reviewer #6
General
Comment
The target audience is well characterized on page 43.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/childhood-cancer-disposition-comments.pdf
February 16, 2022 - The target population
and audience are explicitly defined and the key questions are
appropriate and … The target population is clearly defined.
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia_horizon-scan-high_impact-1306-revised.pdf
July 09, 2013 - potential diffusion (e.g., in
phase III trials or for which some preliminary efficacy data in the target … Intranasal delivery
bypasses the blood-brain barrier to target
therapeutic agents to the central
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1312.pdf
December 01, 2013 - potential diffusion (e.g., in
phase III trials or for which some preliminary efficacy data in the target … Intranasal delivery
bypasses the blood-brain barrier to target
therapeutic agents to the central